Short Interest in Eurofins Scient (OTCMKTS:ERFSF) Increases By 63.2%

Eurofins Scient (OTCMKTS:ERFSF) was the recipient of a large growth in short interest in January. As of January 30th, there was short interest totaling 141,869 shares, a growth of 63.2% from the January 15th total of 86,941 shares. Based on an average daily volume of 5,929 shares, the days-to-cover ratio is currently 23.9 days. Currently, 0.1% of the company’s stock are sold short. Currently, 0.1% of the company’s stock are sold short. Based on an average daily volume of 5,929 shares, the days-to-cover ratio is currently 23.9 days.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on ERFSF shares. Citigroup reissued a “neutral” rating on shares of Eurofins Scient in a research report on Monday, February 2nd. BNP Paribas Exane upgraded shares of Eurofins Scient to an “outperform” rating in a research note on Monday, January 5th. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Eurofins Scient in a research report on Wednesday, October 29th. One investment analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold”.

Eurofins Scient Price Performance

Shares of ERFSF opened at $79.31 on Friday. The company has a quick ratio of 1.19, a current ratio of 1.26 and a debt-to-equity ratio of 0.77. Eurofins Scient has a 52-week low of $48.55 and a 52-week high of $86.20. The stock has a 50 day moving average price of $77.71 and a 200 day moving average price of $74.83.

Eurofins Scient Company Profile

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.